Menu
Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 1
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1475)
- Volume 19, 2023 (65)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 4, 2008
Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!
Claudia S Vetter-Kauczok, Philipp Ströbel, Eva B Bröcker, Jürgen C Becker
Vascular Health and Risk Management 2008, 4:263-266
Published Date: 8 February 2008
A hazardous finding of a rare anomalous left main coronary artery in a patient with a secundum atrial septal defect
Michael Emery, Waqas Ghumman, Shawn Teague, Jo Mahenthiran
Vascular Health and Risk Management 2008, 4:259-262
Published Date: 8 February 2008
Dissection of the ascending thoracic aorta as a complication of percutaneous coronary intervention
Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir
Vascular Health and Risk Management 2008, 4:253-257
Published Date: 8 February 2008
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension
Bernard Waeber, Jean-Jacques Mourad
Vascular Health and Risk Management 2008, 4:249-252
Published Date: 8 February 2008
Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy
B Shivananda Nayak, Heidi Duncan, Sunita Lalloo, Kevin Maraj, Vani Matmungal, et al
Vascular Health and Risk Management 2008, 4:243-247
Published Date: 8 February 2008
Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet
Oluwatosin A Adaramoye, Olajumoke Akintayo, Jonah Achem, Michael A Fafunso
Vascular Health and Risk Management 2008, 4:235-241
Published Date: 8 February 2008
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
Giorgio L Colombo, Mauro Caruggi, Chiara Ottolini, Aldo P Maggioni
Vascular Health and Risk Management 2008, 4:223-234
Published Date: 8 February 2008
Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals
Steven G Denniss, Thomas D Haffner, Jeffrey T Kroetsch, Sara R Davidson, James WE Rush, Richard L Hughson
Vascular Health and Risk Management 2008, 4:213-222
Published Date: 8 February 2008
Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians
S Kanjilal, VS Rao, M Mukherjee, BK Natesha1, KS Renuka, et al
Vascular Health and Risk Management 2008, 4:199-211
Published Date: 8 February 2008
Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective
Saikat Kanjilal, Jayashree Shanker, Veena S Rao, Natesha B Khadrinarasimhaih, Manjari Mukherjee, et al
Vascular Health and Risk Management 2008, 4:189-197
Published Date: 8 February 2008
Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population
Deirdre F Waterhouse, Ronan A Cahill, Frances Sheehan, CJ McCreery
Vascular Health and Risk Management 2008, 4:177-187
Published Date: 8 February 2008
Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study
Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir
Vascular Health and Risk Management 2008, 4:173-176
Published Date: 8 February 2008
Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients
Tiago Tribolet de Abreu, Sonia Mateus, Cecilia Carreteiro, Jose Correia
Vascular Health and Risk Management 2008, 4:167-172
Published Date: 8 February 2008
Adherence treatment factors in hypertensive African American women
Marie N Fongwa, Lorraines S Evangelista, Ron D Hays, David S Martins, David Elashoff, et al
Vascular Health and Risk Management 2008, 4:157-166
Published Date: 8 February 2008
Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
Michel R Hoenig
Vascular Health and Risk Management 2008, 4:143-156
Published Date: 8 February 2008
Update on the use of fibrates: focus on bezafibrate
Ilan Goldenberg, Michal Benderly, Uri Goldbourt
Vascular Health and Risk Management 2008, 4:131-141
Published Date: 8 February 2008
Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes
Andre Pascal Kengne, Anastase Dzudie, Eugene Sobngwi
Vascular Health and Risk Management 2008, 4:123-130
Published Date: 8 February 2008
Endoplasmic reticulum stress and diabetic retinopathy
Toshiyuki Oshitari, Natsuyo Hata, Shuichi Yamamoto
Vascular Health and Risk Management 2008, 4:115-122
Published Date: 8 February 2008
Chronic heart failure in Japan: Implications of the CHART studies
Nobuyuki Shiba, Hiroaki Shimokawa
Vascular Health and Risk Management 2008, 4:103-113
Published Date: 8 February 2008
Endothelial effects of antihypertensive treatment: focus on irbesartan
Roberto Negro
Vascular Health and Risk Management 2008, 4:89-101
Published Date: 8 February 2008
Diagnosis and surgical approach of popliteal artery entrapment syndrome: a retrospective study
Stavros Gourgiotis, John Aggelakas, Nikolaos Salemis, Charalabos Elias, Charalabos Georgiou
Vascular Health and Risk Management 2008, 4:83-88
Published Date: 8 February 2008
Perioperative use of statins in noncardiac surgery
YC Chan, SW Cheng, MG Irwin
Vascular Health and Risk Management 2008, 4:75-81
Published Date: 8 February 2008
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
Cesare Cuspidi, Francesca Negri, Alberto Zanchetti
Vascular Health and Risk Management 2008, 4:67-73
Published Date: 8 February 2008
Current role of endovascular therapy in Marfan patients with previous aortic surgery
Ibrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, et al
Vascular Health and Risk Management 2008, 4:59-66
Published Date: 8 February 2008
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
Navin K Kapur, Dominique Ashen, Roger S Blumenthal
Vascular Health and Risk Management 2008, 4:39-57
Published Date: 8 February 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Imad Sheiban, Gianluca Villata, Mario Bollati, Dario Sillano, Marzia Lotrionte, Giuseppe Biondi-Zoccai
Vascular Health and Risk Management 2008, 4:31-38
Published Date: 8 February 2008
Carvedilol in hypertension treatment
Panagiotis C Stafylas, Pantelis A Sarafidis
Vascular Health and Risk Management 2008, 4:23-30
Published Date: 8 February 2008
Androgen therapy and atherosclerotic cardiovascular disease
K-CY McGrath, LS McRobb, AK Heather
Vascular Health and Risk Management 2008, 4:11-21
Published Date: 8 February 2008
Gadofosveset-enhanced magnetic resonance angiography
Mathias Goyen
Vascular Health and Risk Management 2008, 4:1-9
Published Date: 8 February 2008